Menu

Stem Cells Not Rejected

Researchers uncover more evidence that reprogrammed stem cells are not attacked by the immune system, suggesting they may one day serve as effective therapies.

Jan 25, 2013
Dan Cossins

WIKIMEDIA, NISSIM BENVENISTYResearchers have coaxed induced pluripotent stem cells (iPSCs) derived from mice to become several different cell lines and transplanted those cells into genetically identical mice without triggering a strong immune response.

The study, published this week (January 24) in Cell Stem Cell, comes hot on the heels of similar findings reported earlier this month, strengthening the case that cells generated from iPSCs could eventually be used for cell replacement therapy to treat various human diseases.

Because iPSCs can be derived from a patient’s own tissues, researchers believed that transplantation into that patient should not provoke an immune response. But in 2011, Yang Xu’s team at the University of California, Sand Diego, called such assumptions into question when they provided evidence that iPSCs derived from mice were attacked and rejected by the immune system when implanted into genetically identical mice.

This prompted Ashleigh Boyd and colleagues at Boston University Medical School to try a similar experiment themselves. They differentiated mouse-derived iPSCs into three different cell lines with two different methods and assessed the immune response, both in vitro and after transplantation into genetically identical mice. They found no evidence that white blood cell count increased in vitro, nor of immune rejection in the transplant experiments.

The researchers concede that the discrepancy between their results and Xu’s findings may result from transplanting the cells into different parts of the body. Nevertheless, they wrote, “our data support the idea that differentiated cells generated from autologous iPSCs could be applied for cell replacement therapy without eliciting immune rejection.”

April 2019

Will Car T Cells Smash Tumors?

New trials take the therapy beyond the blood

Marketplace

Sponsored Product Updates

Getting More Consistent Results by Knowing the Quality of Your Protein
Getting More Consistent Results by Knowing the Quality of Your Protein
Download this guide from NanoTemper to learn how to identify and evaluate the quality of your protein samples!
Myth Busting: The Best Way to Use Pure Water in the Lab
Myth Busting: The Best Way to Use Pure Water in the Lab
Download this white paper from ELGA LabWater to learn about the role of pure water in the laboratory and the advantages of in-house water purification!
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu Corporation announces the release of the Nexera Ultra High-Performance Liquid Chromatograph series, incorporating artificial intelligence as Analytical Intelligence, allowing systems to detect and resolve issues automatically. The Nexera series makes lab management simple by integrating IoT and device networking, enabling users to easily review instrument status, optimize resource allocation, and achieve higher throughput.
IDT lowers genomic barriers with powerful rhAmpSeq™ targeted sequencing system
IDT lowers genomic barriers with powerful rhAmpSeq™ targeted sequencing system
Increasing accuracy and reducing cost barriers, IDT’s innovative system delivers simple and cost-effective amplicon sequencing